- Home
- MI vs MBRX Comparison
MI vs MBRX Comparison
Compare MI & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MI
- MBRX
- Stock Information
- Founded
- MI 2009
- MBRX 2015
- Country
- MI Hong Kong
- MBRX United States
- Employees
- MI N/A
- MBRX N/A
- Industry
- MI Catalog/Specialty Distribution
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MI Consumer Discretionary
- MBRX Health Care
- Exchange
- MI Nasdaq
- MBRX Nasdaq
- Market Cap
- MI 26.1M
- MBRX 5.7M
- IPO Year
- MI N/A
- MBRX 2016
- Fundamental
- Price
- MI $2.66
- MBRX $1.87
- Analyst Decision
- MI
- MBRX Strong Buy
- Analyst Count
- MI 0
- MBRX 2
- Target Price
- MI N/A
- MBRX $24.00
- AVG Volume (30 Days)
- MI 147.1K
- MBRX 60.9K
- Earning Date
- MI 01-01-0001
- MBRX 11-08-2024
- Dividend Yield
- MI N/A
- MBRX N/A
- EPS Growth
- MI N/A
- MBRX N/A
- EPS
- MI 1.16
- MBRX N/A
- Revenue
- MI $1,273,946.00
- MBRX N/A
- Revenue This Year
- MI N/A
- MBRX N/A
- Revenue Next Year
- MI N/A
- MBRX N/A
- P/E Ratio
- MI $2.40
- MBRX N/A
- Revenue Growth
- MI N/A
- MBRX N/A
- 52 Week Low
- MI $2.05
- MBRX $0.40
- 52 Week High
- MI $16.70
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- MI 35.51
- MBRX 46.25
- Support Level
- MI $2.60
- MBRX $1.65
- Resistance Level
- MI $3.60
- MBRX $1.95
- Average True Range (ATR)
- MI 0.90
- MBRX 0.21
- MACD
- MI -0.20
- MBRX 0.02
- Stochastic Oscillator
- MI 1.24
- MBRX 75.51
About MI NFT Limited
NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.